Dr. Steven Rimbaut - Fysische Geneeskunde en Revalidatie
0663.757.439 · rovalta.com · 28/09/2026
NORMAL SITUATION
Dr. Steven Rimbaut - Fysische Geneeskunde en Revalidatie
Company — Normal situation.
Financial year 2025 · Closed on 10/12/2025
Net result7,3 k €-87,7 %over 1 year
Gross margin-17,2 k €-118,9 %over 1 year
Overview
Identity
Source · BCE/KBODr. Steven Rimbaut - Fysische Geneeskunde en Revalidatie is a company registered in Belgium.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0663.757.439
- Legal form
- Private limited company
- Latest accounts
- 10/12/2025
Signals
ProfitablePositive cashflow
Financials
Source · NBB, 10 filingsTrend over 10 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | -17,2 k € | -119% | 90,8 k € | -41.8% | 156,2 k € | -23.7% | 204,6 k € | +94.6% | 105,2 k € |
| EBITDA | -18,2 k € | -121% | 86 k € | -44.4% | 154,9 k € | -24.0% | 203,7 k € | +94.9% | 104,5 k € |
| Operating result | -18,2 k € | -122% | 83,6 k € | -40.8% | 141,3 k € | -27.0% | 193,6 k € | +114% | 90,5 k € |
| Net result | 7,3 k € | -87.7% | 59,4 k € | -37.6% | 95,3 k € | -29.5% | 135,2 k € | +107% | 65,2 k € |
| Balance sheet | |||||||||
| Equity | – | 477,7 k € | +14.0% | 419,1 k € | +29.1% | 324,6 k € | +70.7% | 190,2 k € | |
| Total assets | 5,8 k € | -98.8% | 479,3 k € | +14.0% | 420,4 k € | +19.5% | 351,8 k € | +82.1% | 193,2 k € |
| Cash | 5,8 k € | -64.5% | 16,2 k € | -87.8% | 133,5 k € | -52.7% | 282,3 k € | +61.0% | 175,4 k € |
| Debts | 5,8 k € | +264% | 1,6 k € | +20.3% | 1,3 k € | -95.1% | 27,2 k € | +800% | 3 k € |
Board of directors
Source · NBB, accounts to 10/12/20251 active
Active mandates
| Director | Mandates in this company | Period |
|---|---|---|
Steven RIMBAUT | Directorsince 03/10/2016Managersince 03/10/2016ended |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 10/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 12/01/2026 | 13/07/2025 | 01/07/2024 | 31/07/2023 | 15/06/2022 | 14/06/2021 |
| General meeting | – | 30/06/2025 | 25/06/2024 | 29/06/2023 | 13/06/2022 | 10/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 10 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 10/12/2025 | — | 12/01/2026 | Dutch | |
| Micro model | 31/12/2024 | 30/06/2025 | 13/07/2025 | Dutch | |
| Micro model | 31/12/2023 | 25/06/2024 | 01/07/2024 | Dutch | |
| Micro model | 31/12/2022 | 29/06/2023 | 31/07/2023 | Dutch | |
| Micro model | 31/12/2021 | 13/06/2022 | 15/06/2022 | Dutch | |
| Micro model | 31/12/2020 | 10/06/2021 | 14/06/2021 | Dutch | |
| Micro model | 31/12/2019 | 15/06/2020 | 20/06/2020 | Dutch | |
| Micro model | 31/12/2018 | 17/06/2019 | 03/07/2019 | Dutch | |
| Micro model | 31/12/2017 | 27/06/2018 | 02/07/2018 | Dutch | |
| Micro model | 31/12/2016 | 19/06/2017 | 28/06/2017 | Dutch |
Valuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 10/12/20251 active
Active mandates
| Director | Mandates in this company | Period |
|---|---|---|
Steven RIMBAUT | Directorsince 03/10/2016Managersince 03/10/2016ended |
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official GazetteSimilar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsYear
Identity
Name
Registered office
Annual accounts
Filings10 filings
Mandates
Steven RIMBAUT
20162017201820192020202120222023202420252026
Dr. Steven Rimbaut - FGR
Vrankrijkstraat 14, 9200 Dendermonde
CurrentPlanned, not yet servedEndedAccounts filedToday
Registered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Vrankrijkstraat 14, 9200 Dendermonde | accounts 2021 → 2025 | Accounts 2025 · 2026-00005817 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| Dr. Steven Rimbaut - FGR - vereff. | accounts 2025 | Accounts 2025 · 2026-00005817 |
| Dr. Steven Rimbaut - FGR | accounts 2021 → 2024 | Accounts 2024 · 2025-00262320 |
Events
- 2025Annual accounts 20257,3 k €↓
- 2025Name changeDr. Steven Rimbaut - FGR - vereff.
- 2024Annual accounts 202459,4 k €↓
- 2023Annual accounts 202395,3 k €↓
- 2022Annual accounts 2022135,2 k €↑
- 2021Annual accounts 202165,2 k €↑
- 2020Annual accounts 202063,3 k €↑
- 2019Annual accounts 201917,1 k €↑
- 2018Annual accounts 201811,3 k €↑
- 2017Annual accounts 201710,6 k €↑
- 2016Annual accounts 20167,9 k €